Brief: Werewolf Therapeutics Reports Q1 2023 Financial Results And Provides Business Update
May 11 (Reuters) - Werewolf Therapeutics Inc HOWL.O :
* WEREWOLF THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* WEREWOLF THERAPEUTICS INC Q1 LOSS PER SHARE $0.34
* WEREWOLF THERAPEUTICS INC - QTRLY COLLABORATION REVENUE
$4.5
MILLION
Source text for Eikon: ID:nGNX7rwXNW
Further company coverage: HOWL.O
((Reuters.Briefs@thomsonreuters.com;))